Home » Newsletters » The Carlat Addiction Treatment Report

The Carlat Addiction Treatment Report

Legal Issues in Addiction Medicine (July/August) | 2019

View Archived Issues

CME Post-Test - Legal Issues in Addiction Medicine, CATR, July/August 2019

August 1, 2019

The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 1 CME credit. Read More

Gabapentin Enacarbil XR Efficacy Less Than Expected for AUD

August 1, 2019

Thomas Jordan, MD

This 2019 randomized, double-blind, placebo- controlled trial study casts doubt on using gabapentin enacarbil extended-release (GE-XR) (Horizant), an extended-release version of gabapentin, for treatment in patients with alcohol use disorder Read More

Can Buprenorphine Improve PTSD Symptoms?

August 1, 2019

Thomas Jordan, MD

This 2019 retrospective study examines the potential benefits of using buprenorphine/naloxone to treat co-occurring PTSD and opioid use disorder. Read More

Opioid Use Disorder: Is There an App for That?

August 1, 2019

Joshua Sonkiss, MD.

This News of Note discusses the first FDA-approved mobile app for SUDs, called reSET-O. Classified as a mobile medical app (MMAs), reSET-O can be used as an adjunct to outpatient opioid use disorder treatment. Unlike most apps, reSET-O requires a prescription to unlock and use. Read More

New Generic Versions of Naloxone

August 1, 2019

Talia Puzantian, PharmD, BCPP.

Naloxone, a rescue medication effective for reversing opioid overdose, will soon be available in two generic forms for layperson use. This news of note summarizes these generic, lower-cost products. Read More

Treating Addiction in Patients Transitioning to/from Incarceration

August 1, 2019

Karen Cropsey, PsyD

Addiction treatment during incarceration is limited, and release from incarceration presents its own set of challenges. In this QA interview, Dr. Karen Cropsey discusses effective treatment options for patients with substance use disorders transitioning to or from incarceration. Read More

Primer: Confidentiality in Addiction Treatment

August 1, 2019

Addiction is stigmatized, resulting in historically strict confidentiality rules. But how do we interpret HIPAA and other regulations in 2019 addiction practice? Do we need a ROI every time we communicate with other clinicians/institutions, which seems cumbersome and counterproductive? In this article we cover what you need to know about confidentiality in addiction treatment. Read More